Kinvard Bio News and Resources

Kineticos Life Sciences has announced the launch of Kinvard Bio, Inc., a biotech company dedicated to developing new antibiotics to combat antimicrobial resistance (AMR). The company is built on research licensed exclusively from Harvard University’s Myers Lab and is financially supported by Kineticos